stockmarketproxy
/
GMEDNYSE SEC EDGAR

GLOBUS MEDICAL INC

Surgical & Medical Instruments & Apparatus·AUDUBON, PA·FY end 12/31·CIK 1237831
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$2.9B$2.5B$1.6B$1.0B$958.1M
Gross Profit——$1.0B$759.1M$718.9M
Operating Income$479.8M$166.0M$133.1M$228.0M$172.0M
Net Income$537.9M$103.0M$122.9M$190.2M$149.2M
Operating CF$753.4M$520.6M$243.5M$178.5M$276.3M
Capex$164.7M$115.4M$78.3M$74.0M$56.9M
Free Cash Flow$588.8M$405.2M$165.2M$104.4M$219.4M
Buybacks$300.5M$85.8M$225.6M$144.5M—
Dividends——————
Gross Margin——65.1%74.2%75.0%
Operating Margin16.3%6.6%8.5%22.3%17.9%
Net Margin18.3%4.1%7.8%18.6%15.6%
FCF Margin20.0%16.1%10.5%10.2%22.9%
R&D / Revenue5.0%6.5%7.9%7.1%10.2%
Effective Tax11.1%14.7%25.7%21.7%17.3%
Debt / Equity——————
Buybacks / FCF51.0%21.2%136.5%138.4%—

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
GMED
35:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
GMED
$4M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
GMED
18.3%
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%